全文获取类型
收费全文 | 3113篇 |
免费 | 223篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 32篇 |
儿科学 | 104篇 |
妇产科学 | 65篇 |
基础医学 | 352篇 |
口腔科学 | 53篇 |
临床医学 | 310篇 |
内科学 | 779篇 |
皮肤病学 | 71篇 |
神经病学 | 164篇 |
特种医学 | 106篇 |
外科学 | 555篇 |
综合类 | 98篇 |
一般理论 | 1篇 |
预防医学 | 182篇 |
眼科学 | 55篇 |
药学 | 220篇 |
中国医学 | 12篇 |
肿瘤学 | 181篇 |
出版年
2021年 | 62篇 |
2020年 | 28篇 |
2019年 | 58篇 |
2018年 | 51篇 |
2017年 | 46篇 |
2016年 | 55篇 |
2015年 | 66篇 |
2014年 | 69篇 |
2013年 | 111篇 |
2012年 | 156篇 |
2011年 | 188篇 |
2010年 | 86篇 |
2009年 | 96篇 |
2008年 | 116篇 |
2007年 | 132篇 |
2006年 | 135篇 |
2005年 | 123篇 |
2004年 | 122篇 |
2003年 | 91篇 |
2002年 | 79篇 |
2001年 | 60篇 |
2000年 | 83篇 |
1999年 | 55篇 |
1998年 | 33篇 |
1997年 | 28篇 |
1995年 | 21篇 |
1992年 | 84篇 |
1991年 | 45篇 |
1990年 | 55篇 |
1989年 | 50篇 |
1988年 | 51篇 |
1987年 | 54篇 |
1986年 | 45篇 |
1985年 | 45篇 |
1984年 | 28篇 |
1983年 | 22篇 |
1982年 | 20篇 |
1980年 | 20篇 |
1979年 | 45篇 |
1978年 | 33篇 |
1977年 | 34篇 |
1976年 | 21篇 |
1975年 | 30篇 |
1974年 | 30篇 |
1973年 | 49篇 |
1972年 | 36篇 |
1971年 | 25篇 |
1970年 | 22篇 |
1969年 | 25篇 |
1968年 | 20篇 |
排序方式: 共有3340条查询结果,搜索用时 15 毫秒
101.
Lalwani S Govindasamy M Gupta M Siraj F Varma V Mehta N Kumaran V Mohan N Chopra P Arora A Agarwal S Soin A Nundy S 《Indian journal of gastroenterology》2012,31(3):139-143
Mucormycosis of the gastrointestinal tract is a rare infection that usually occurs in patients who are immunocompromised and carries a high mortality. We report four cases of gastrointestinal mucormycosis seen over a one year period with different presentations, risk factors and different anatomical sites of involvement. A preoperative diagnosis was made only in one patient. All underwent surgery, three survived and one died postoperatively from multiorgan failure. 相似文献
102.
103.
Biologic disease modifying anti-rheumatic drugs (DMARD) have revolutionized the management of several rheumatic disorders, especially those with autoimmune inflammatory etiology. A decade of experience has further endorsed their efficacy and unraveled safety issues. Treat to target remission is the current mantra. Infections remain the single most important complication. However, the access to biologics has been severely restricted by their exorbitant cost. Several biologics will lose their patent in the imminent future. An exact replica of a protein molecule is difficult if not impossible. Molecules seemingly similar to biologics called biosimilars or ‘follow on biologics’ are likely to flood the markets world wide at a challenging and affordable price. However, the acceptability of biosimilars will be driven by several contentious issues connected with manufacture, standardization, extent of validation (compared to source innovator biologic), interchangeability (with biologic), regulatory issues, and other patient centric socioeconomic issues. India is likely to provide a fertile field for biosimilar drugs and patients stand to gain from an expanded access and newer treatment paradigms. The fierce competition between several pharmaceutical companies (Indian and multinationals) to gain supremacy will fuel better affordability, equity and access to medicine while upholding the science of quality drugs. The stage is now set for this next big revolution in therapeutics. 相似文献
104.
Rashim Kataria Virendra D Sinha Sanjeev Chopra Ashok Gupta Nachiket Vyas 《Child's nervous system》2013,29(4):693-697
Background
Ventriculoperitoneal shunt (VPS) surgery is the most common procedure performed for the treatment of hydrocephalus. Erosive bladder perforation by a peritoneal catheter is an extremely rare complication of VPS. Only ten cases involving the normal (non-augmented) urinary bladder have been reported so far.Case
We report a case of erosive bladder perforation, intra-corporeal knot formation, and perurethral extrusion of the distal end of VPS. This is the second only case report so far in the world literature showing triad of uncommon VPS complications in a single patient.Conclusion
Prompt management could avoid further complications. Patient’s parents should be aware about this rare complication, so that they can seek timely medical help. 相似文献105.
JA Horst U Pieper A Sali L Zhan G Chopra R Samudrala JD Featherstone 《Advances in dental research》2012,24(2):86-93
Dental caries is the most common disease to cause irreversible damage in humans. Several therapeutic agents are available to treat or prevent dental caries, but none besides fluoride has significantly influenced the disease burden globally. Etiologic mechanisms of the mutans group streptococci and specific Lactobacillus species have been characterized to various degrees of detail, from identification of physiologic processes to specific proteins. Here, we analyze the entire Streptococcus mutans proteome for potential drug targets by investigating their uniqueness with respect to non-cariogenic dental plaque bacteria, quality of protein structure models, and the likelihood of finding a drug for the active site. Our results suggest specific targets for rational drug discovery, including 15 known virulence factors, 16 proteins for which crystallographic structures are available, and 84 previously uncharacterized proteins, with various levels of similarity to homologs in dental plaque bacteria. This analysis provides a map to streamline the process of clinical development of effective multispecies pharmacologic interventions for dental caries. 相似文献
106.
Satyaveni Malasala Jitendra Gour Md. Naiyaz Ahmad Srikanth Gatadi Manjulika Shukla Grace Kaul Arunava Dasgupta Y. V. Madhavi Sidharth Chopra Srinivas Nanduri 《RSC advances》2020,10(71):43533
A facile method was developed for the synthesis of quinazolinone derivatives in a one-pot condensation reaction via in situ amine generation using ammonia as the amine source and with the formation of four new C–N bonds in good to excellent yields. With the optimised method, we synthesized a library of piperazine linked quinazoline derivatives and the synthesized compounds were evaluated for their inhibitory activity against Mycobacterium tuberculosis. The compounds 8b, 8e, 8f, 8m, 8n and 8v showed potent anti-mycobacterial activity with MIC values of 2–16 μg mL−1. All the synthesized compounds follow Lipinski''s rules for drug likeness.A facile method was developed for the synthesis of quinazolinone derivatives in a one-pot condensation reaction via in situ amine generation using ammonia as the amine source and with the formation of four new C–N bonds in good to excellent yields. 相似文献
107.
108.
109.
Amit Chopra Alexandros Kalkanis Marc A. Judson 《Expert Review of Clinical Immunology》2016,12(11):1191-1208
Introduction: Numerous biomarkers have been evaluated for the diagnosis, assessment of disease activity, prognosis, and response to treatment in sarcoidosis. In this report, we discuss the clinical and research utility of several biomarkers used to evaluate sarcoidosis.
Areas covered: The sarcoidosis biomarkers discussed include serologic tests, imaging studies, identification of inflammatory cells and genetic analyses. Literature was obtained from medical databases including PubMed and Web of Science.
Expert commentary: Most of the biomarkers examined in sarcoidosis are not adequately specific or sensitive to be used in isolation to make clinical decisions. However, several sarcoidosis biomarkers have an important role in the clinical management of sarcoidosis when they are coupled with clinical data including the results of other biomarkers. 相似文献
110.
Human monoclonal antibody AVP-21D9 to protective antigen reduces dissemination of the Bacillus anthracis Ames strain from the lungs in a rabbit model
下载免费PDF全文
![点击此处可从《Infection and immunity》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Peterson JW Comer JE Baze WB Noffsinger DM Wenglikowski A Walberg KG Hardcastle J Pawlik J Bush K Taormina J Moen S Thomas J Chatuev BM Sower L Chopra AK Stanberry LR Sawada R Scholz WW Sircar J 《Infection and immunity》2007,75(7):3414-3424
Dutch-belted and New Zealand White rabbits were passively immunized with AVP-21D9, a human monoclonal antibody to protective antigen (PA), at the time of Bacillus anthracis spore challenge using either nasal instillation or aerosol challenge techniques. AVP-21D9 (10 mg/kg) completely protected both rabbit strains against lethal infection with Bacillus anthracis Ames spores, regardless of the inoculation method. Further, all but one of the passively immunized animals (23/24) were completely resistant to rechallenge with spores by either respiratory challenge method at 5 weeks after primary challenge. Analysis of the sera at 5 weeks after primary challenge showed that residual human anti-PA levels decreased by 85 to 95%, but low titers of rabbit-specific anti-PA titers were also measured. Both sources of anti-PA could have contributed to protection from rechallenge. In a subsequent study, bacteriological and histopathology analyses revealed that B. anthracis disseminated to the bloodstream in some na?ve animals as early as 24 h postchallenge and increased in frequency with time. AVP-21D9 significantly reduced the dissemination of the bacteria to the bloodstream and to various organs following infection. Examination of tissue sections from infected control animals, stained with hematoxylin-eosin and the Gram stain, showed edema and/or hemorrhage in the lungs and the presence of bacteria in mediastinal lymph nodes, with necrosis and inflammation. Tissue sections from infected rabbits dosed with AVP-21D9 appeared comparable to corresponding tissues from uninfected animals despite lethal challenge with B. anthracis Ames spores. Concomitant treatment with AVP-21D9 at the time of challenge conferred complete protection in the rabbit inhalation anthrax model. Early treatment increased the efficacy progressively and in a dose-dependent manner. Thus, AVP-21D9 could offer an adjunct or alternative clinical treatment regimen against inhalation anthrax. 相似文献